Table 4.
PFS | OS | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
N | HR (95% CI) | 2-year PFS probability, % (95% CI) |
3-year PFS probability, % (95% CI) |
4-year PFS probability, % (95% CI) |
n | HR (95% CI) |
2-year OS probability, % (95% CI) |
3-year OS probability, % (95% CI) |
4-year OS probability, % (95% CI) |
|
Model with imaging and clinical variables | ||||||||||
Low-risk patients | 408 | Reference | 84 (80–88) | 81 (77–85) | 78 (74–82) | 422 | Reference | 91 (88–94) | 90 (87–93) | 89 (85–92) |
High-risk patients | 438 | 2.36 (1.82–3.05) | 64 (59–68) | 59 (55–64) | 57 (53–62) | 424 | 2.69 (1.93–3.73) | 79 (75–83) | 74 (69–78) | 71 (67–76) |
Model with clinical variables only | ||||||||||
Low-risk patients | 419 | Reference | 80 (76–84) | 76 (72–81) | 74 (69–78) | 419 | Reference | 90 (87–93) | 88 (85–91) | 86 (82–89) |
High-risk patients | 427 | 1.80 (1.40–2.30) | 67 (63–72) | 63 (58–68) | 61 (56–66) | 427 | 2.03 (1.48–2.78) | 80 (76–84) | 75 (71–80) | 74 (70–78) |
CI Confidence interval, HR Hazard ratio, OS Overall survival, PFS Progression-free survival